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Editorial on the Research Topic
Modulating Glial Cells Phenotype: New Findings and Therapies
Aging and neurodegenerative diseases are closely related, and the common point between both
scenarios is neuroinflammation. Neuroinflammation is mainly mediated by glial cells, astrocytes,
and microglia; while endothelial cells transfer the pro-inflammatory signals from periphery. The
mechanism that underlies glial cells activation and neuroinflammation-related damage is not fully
understood, being the study of glial cells during aging as well as neurodegenerative diseases,
a key point to identify targets and to develop therapies that modulate adverse outcomes and
mitigate neurodegeneration.
This Research Topic has produced a highly informative collection of original research and
reviews, that cover multiple aspects for delving neuroinflammation and glial phenotypic changes in
neurological diseases and aging. Researchers have presented their work and views to explain cellular
and molecular mechanisms acquired by glial cells as well as possible interventions that can modify
their functions and phenotypes associated with a broad spectrum of neurological diseases.
Serapide et al. started by focusing on the pivotal role of astrocytes activation in Parkinson’s
disease (PD), the most common age-dependent movement disorder. These authors tried a new
approach to uncover the interaction between the astrocytes and neurons in PD mice brains.
They demonstrate that grafting astrocytes alleviate oxidative stress in a parkinsonian brain by
using MPTP-induced PD mice. Adding new information, Rabaneda-Lombarte et al. investigated
the effect of MPP+ or rotenone to microglial/astroglial functions. Their manuscript provides
information on the impact of PD-related toxins on the phenotype of glia, based on the evaluation
of the mRNA levels of various gene products.
Deepen on astrocytes functions, the astrocyte-specific enzyme glutamine synthetase plays an
essential role in supporting neurotransmission and in limiting ammonium toxicity. Moreover,
deficits in Glutamine synthetase activity contribute to epilepsy and neurodegeneration. In this
regard, Huyghe et al. extensively investigated the regulation of glutamine synthetase by PKA at
T301 using biochemical and cell biological approaches. The authors successfully created two anti-
phospho-GS antibodies and demonstrated that phosphorylation of T301 is critical for its activity in
astrocytes. This modification results in decreased enzyme activity in a mouse model of epilepsy.
To provide new insights into microglial implication in behavioral changes induced by infections
and mediated by pro-inflammatory cytokines, Savage et al. describe for the first time the effects
of acute LPS on the ultrastructure of microglia in the mouse hippocampus. The ultrastructural
changes found by the authors, provide an excellent starting point to determine pro-inflammatory
and phagocytic pathways engaged by in sickness behavior.
Another interesting aspect of glial cells participation on pathological conditions was reviewed
by Zang et al.. Their work was focused on the role of epigenetic regulation in the pathogenesis of
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glioma and discuss its value as therapeutic target for the
treatment of this disease. Authors expand our knowledge on four
epigenetic phenomena that occur in glioma: DNA methylation,
abnormal microRNA, histone modifications, and chromatin
remodeling. They review current epigenetic treatments for
glioma, such as inhibitors of DNA methyltransferase and histone
deacetylation inhibitors and argument the limitations of their
applications due to the complicated pathogenesis of glioma.
Various articles in this collection focus on the role and
mechanisms of astrocytes and microglia in the aging brain.
Current issues and novel findings in the modulation of glial cells
and the pathways able to promote healthy aging will provide
a better understanding of cellular and molecular mechanisms
toward a neuroprotective or a deleterious glial phenotype.
Related with this topic, Matias et al. introduced the concept
of astrocyte heterogeneity, which is a hot topic in the field.
The review addressed diverse phenotypes of astrocytes with
an emphasis on aging and neurodegenerative conditions. The
authors discussed historical overview of astrocytes, astrocyte
heterogeneity in healthy brain and pathological conditions,
concept of “inflammaging,” and selective vulnerability. Also,
they present the possibility of using glia as target for
therapeutic strategies.
Expanding the knowledge of the changes undergone by
astrocytes during aging, Zárate et al. investigated the role of
Humanin, an astrocyte-release mitochondrial peptide, and the
influence of hormonal milieu. They analyzed the role of this
protein on synaptic dysfunction in the context of hormonal
decline as a model of aging. The study of Humanin regulation
by ovarian hormones in the brain is novel and highly interesting,
given the plethora of molecular targets that these hormones
have and that participate in mediating their neuroprotective
and neuro-restorative.
Continuing with the study of glial-cells changes during aging,
Falomir-Lockhart et al. investigated the effects of IGF-1 gene
therapy onmicroglia. Importantly, these authors found that IGF1
therapy leads to a region-specific modification of aged microglia
population. Microglia cells become dystrophic with aging; which
contributes to basal central nervous system neuroinflammation
being a risk factor for age-related neurodegenerative diseases.
These authors’ findings suggest that such a therapy may be useful
to alter the function of dystrophic microglia effects.
Another study by Trias et al. explores the emergence of
senescent microglia in spinal cord during paralysis progression
in amyotrophic lateral sclerosis (ALS) rat model (SOD1G93A).
The authors showed nuclear p16INK4a expression in
activated microglia during paralysis progression as well as
in a subpopulation of spinal motor neurons and astrocytes.
They suggest that cellular senescence is closely associated with
inflammation and motor neuron loss occurring after paralysis
onset in SOD1G93A rats. The emergence of senescent cells could
mediate key pathogenic mechanisms in ALS.
With the increment of life expectancy, preventive measures,
and treatments for age-related cognitive decline, and dementia
are of utmost importance. The work by Ano et al. shows that
both chronic and acute administration of Iso-alpha-acids (IAA)
prevents the neuroinflammation and cognitive decline associated
with aging. The use of natural compounds as IAA, which are
hop-derived bitter compounds in beer, represent an interesting
therapeutic tool to ameliorate age-related negative outcomes.
Later on, Velasco-Estevez et al. used an aging transgenic rat
model of Alzheimer Disease (AD) to study the expression of
mechanosensing Piezo1 ion channels in amyloid plaque-reactive
astrocytes. Piezo1 is a non-selective mechanosensory mediating
cation channel. The authors found that aging and peripheral
infection augment amyloid plaque-induced upregulation of
mechanoresponsive ion channels, such as Piezo1, in astrocytes.
Additional work is required to investigate the role of astrocytic
Piezo1 in the Alzheimer’s brain and its possible use as a novel
drug target for age-related dementia.
Microglia polarization to an anti-inflammatory phenotype
has been described to be neuroprotective. In the study by Jin
et al., they linked microglial pro-inflammatory polarization
to neuroinflammation and autophagy dysfunction, that are
closely related to the development of neurodegeneration
in Parkinson’s disease. They demonstrate that TNF-α
inhibits autophagy in microglia through AKT/mTOR
signaling pathway, and autophagy enhancement can
promote microglia polarization toward anti-inflammatory
phenotype and inflammation resolution. This study
adds information to establish which specific factors are
responsible for disturbing the pro-/anti-inflammatory
balance in areas where inflammatory stimuli induce
neurodegeneration. Besides the study contributes to
understanding the relationship between inflammation and
autophagy processes.
Together these articles have brought several interesting
understandings of neuroinflammation and glial cells activation
in a range of neurological diseases and aging. We expect that this
topic would expand our knowledge of the mechanisms whereby
reactive glial cells could be detrimental or neuroprotective.
Moreover, this comprehension could contribute for the
development of therapeutics to limit neuroinflammation or even
slow down the process of aging.
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